Telemedicine, diabetes and endocrinologic diseases in the COVID-19 era: the patients’ point of view from a high impacted area. (Preprint)
BACKGROUND The effectiveness of telemedicine has been widely investigated, also in a diabetologic setting. Available evidence support an important role of telemedicine in emergency times, like the present COVID-19 outbreak. OBJECTIVE The aim of the study is to evaluate the feasibility and patient satisfaction associated with virtual visit use in an outpatient diabetology and endocrinology unit in Pavia, Italy, during the present COVID-19 pandemic. METHODS We submitted a custom-made satisfaction questionnaire to each patient who underwent a televisit from the 1st of April to the 1st of May 2020. The questionnaire was proposed to 51 subjects. Furthermore, the patients were asked about their gender, age and visit reason. RESULTS All patients accepted to answer our questionnaire. Their mean age was of 38 years (minimum 20, maximum 79) and most of patients were women (39). The patients resulted affected by different disease: type 1, type 2 and gestational diabetes, hypothyroidism during pregnancy, Graves’ disease, Klinefelter Syndrome, Acromegaly, Cushing syndrome and hypopituitarism. The majority of them didn’t find any difficulty in using the informatic system, recognized a value of telemedicine in preventing COVID-19 contagion, and considered the tele-visit useful. CONCLUSIONS Our results show that patients were overall satisfied of this new approach. Telemedicine, also in a diabetologic and endocrinologic setting, can be of help in providing continuing healthcare, while keeping health providers and patients safe during COVID-19 pandemic. CLINICALTRIAL